A huge loss to science. www.nytimes.com/2025/09/07/s...

NIH-research and NIH-funded research saves lives www.nature.com/articles/s41...

Very cool study

ICYMI - over the summer Maria Parkhurst from our branch published one of the first reports of clinical responses after adoptive cell transfer of TCR engineered private neoantigen (tumor mutation) targeting T cells in metastatic cancer patients 🧪🦠🔬🩺 1/3 #Immunosky www.nature.com/articles/s41...

Reposting this now that there’s more crowd here - it was lonely a year back 🧪🦠

Can we find antitumor, neoantigenT cells and predict their TCRs in the blood of patients with metastatic solid tumors? How do their phenotypes compare to those within patient's tumor? We addressed these questions in our new Cancer_Cell study.

Another day, another award for our branch chief Steve Rosenberg. This time, the Presidential National Medal of technology and innovation, for pioneering immunotherapy against cancer. 🧪🔬🦠🩺 #ImmunoSky www.cancer.gov/news-events/...

As probably one of the few NIH researchers on here, I feel obligated to note that a US federal govt shutdown will also impact the approx 1500 clinical trials being conducted at the NIH, including those against cancer, Alzheimer's, and many other diseases. Hopefully it is averted. 🩺🦠🔬🧪

🧪🔬🦠🩺Pls share. We are evaluating postdoc candidates with interests computational or experimental immunology, or tumor biology, immunotherapy, T cell immunology, or genome engineering. ccr.cancer.gov/careers/post...

Hi Bluesky. I recently started my lab at the Surgery Branch, National Cancer Institute. We study T cell Immunology in human cancer patients with the goal of developing cell therapies. Pls share this, join us if you're interested! We are looking for postdocs! ccr.cancer.gov/staff-direct...